Loading patent…
AssigneeMect Corporation
InventorsMasaaki Numata, Shigeki Nunomura, Shuji Fujita, Masami Iida, Akira Endo, Takayuki Ishii, Tomoya Ogawa, Mamoru Sugimoto, Ryoichi Osawa, Masamichi Fujita
Estimating the term…
A Lewis-associated compound, represented by general formula (I), a process for producing the same, and an anti-inflammatory, wherein R.sup.1 and R.sup.3 represent each hydrogen, m SO.sub.3 H or CH.sub.2 COOH; R.sup.2 represents hydrogen, SO.sub.3 H, CH.sub.2 COOH or N-acetyl-neutraminic acid residue; R.sup.4 represents hydrogen; R.sup.5 represents O-lower alkyl, O-lower alkenyl, O-ceramide residue, O-mannose residue, O-galactose residue or O-lactose residue; R.sup.6 represents acetylamine; and R.sup.7 and R.sup.8 represent each hydrogen. ##STR1##
A Lewis-associated compound, represented by the formula (I), (II), (III), (IV), (V) or (VI):
A Lewis-associated compound, represented by formula (VII), (IX) or (X):
An anti-inflammatory agent comprising a Lewis-associated compound represented by general formula (III), (IV), (V) or (VI), or a pharmacologically acceptable salt thereof as an effective component:
A process for producing compound 86, comprising the steps of:
Dependencies are inferred from the claim text.